Real-time enrollment status for this pancreatic cancer clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 10:47 AM UTC
| NCT Number | NCT04048278 |
| Recruiting Status | Recruiting |
| Condition | Pancreatic Cancer |
| Phase | EARLY_PHASE1 |
| Target Enrollment | 46 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Illinois at Chicago |
| Last Updated on CT.gov | June 15, 2026 (Jun 15, 2026) |
As of July 18, 2026: Clinical trial NCT04048278 is currently recruiting participants. This early_phase1 study for pancreatic cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Illinois at Chicago. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04048278 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04048278 was last updated Jun 15, 2026 (June 15, 2026). HelloStudys verifies this status automatically.